Literature DB >> 25737044

APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice.

Ye Zhou1, Wenjuan Zhao2, Nour Al-Muhtasib3, G William Rebeck4.   

Abstract

Apolipoprotein E (APOE) alleles are strongly related to the risk of Alzheimer's disease (AD). APOE genotype also affects inflammatory processes in response to damage. We tested whether APOE genotype affected the levels of specific immunoglobulins in healthy, uninfected APOE knock-in mice. We measured specific immunoglobulins in brain, spleen, and plasma. Levels of total IgG in brain and spleen were highest in APOE-ɛ3 mice, significantly higher than in APOE-ɛ2 and APOE-ɛ4 mice; no differences were observed for levels of total IgG in plasma. We also measured specific subtypes of IgG. IgG1 was only detectable in plasma and did not differ by APOE genotype. IgG3 was detectable in plasma and spleen, and also did not differ by APOE genotype. IgG2b showed the same pattern as levels of total IgG by APOE genotype, with the highest levels of IgG2b in brain, spleen, and plasma of APOE-ɛ3 mice. IgG2a showed an entirely different pattern, with significantly higher levels in spleen and plasma of APOE-ɛ4 mice compared to APOE-ɛ2 and APOE-ɛ3 mice. We also measured IgM and IgA in spleens and plasma of these mice. In spleen, APOE-ɛ4 mice had the lowest IgA levels and the highest levels of IgM; both being significantly different from APOE-ɛ2 mice. In total, murine IgG2a and IgM were highest in APOE-ɛ4 mice, while total IgG and Ig2b were highest in APOE-ɛ3 mice. These dramatically different distributions of immunoglobulins could allow for human AD risk biomarkers based on specific immunoglobulin subtypes.

Entities:  

Keywords:  Apolipoprotein E; brain; immunoglobulin; inflammation; plasma; spleen

Mesh:

Substances:

Year:  2015        PMID: 25737044      PMCID: PMC4963980          DOI: 10.3233/JAD-142184

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  47 in total

Review 1.  Immunoglobulin class switching.

Authors:  J Stavnezer
Journal:  Curr Opin Immunol       Date:  1996-04       Impact factor: 7.486

Review 2.  The neuroprotective role of inflammation in nervous system injuries.

Authors:  Jorge Correale; Andrés Villa
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 3.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

4.  Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2.

Authors:  Y Kawano; T Noma; J Yata
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

5.  APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response.

Authors:  John R Lynch; Wen Tang; Haichen Wang; Michael P Vitek; Ellen R Bennett; Patrick M Sullivan; David S Warner; Daniel T Laskowitz
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

6.  Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity.

Authors:  M E Kelly; M A Clay; M J Mistry; H M Hsieh-Li; J A Harmony
Journal:  Cell Immunol       Date:  1994-12       Impact factor: 4.868

7.  A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.

Authors:  Ling Guo; Mary Jo LaDu; Linda J Van Eldik
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Intracranial injection of Gammagard, a human IVIg, modulates the inflammatory response of the brain and lowers Aβ in APP/PS1 mice along a different time course than anti-Aβ antibodies.

Authors:  Tiffany L Sudduth; Abigail Greenstein; Donna M Wilcock
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

10.  Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.

Authors:  M Britschgi; C E Olin; H T Johns; Y Takeda-Uchimura; M C LeMieux; K Rufibach; J Rajadas; H Zhang; B Tomooka; W H Robinson; C M Clark; A M Fagan; D R Galasko; D M Holtzman; M Jutel; J A Kaye; C A Lemere; J Leszek; G Li; E R Peskind; J F Quinn; J A Yesavage; J A Ghiso; T Wyss-Coray
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

View more
  5 in total

1.  Antibodies against neural antigens in patients with acute stroke: joint results of three independent cohort studies.

Authors:  Georg Royl; Tsafack Judicael Fokou; Rittika Chunder; Rakad Isa; Thomas F Münte; Klaus-Peter Wandinger; Markus Schwaninger; Oliver Herrmann; José Manuel Valdueza; Jan Brocke; Martin Willkomm; Dietrich Willemsen; Gerd U Auffarth; Swantje Mindorf; Britta Brix; Angel Chamorro; Anna Planas; Xabier Urra
Journal:  J Neurol       Date:  2019-07-29       Impact factor: 4.849

2.  RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.

Authors:  Iliya Lefterov; Jonathan Schug; Anais Mounier; Kyong Nyon Nam; Nicholas F Fitz; Radosveta Koldamova
Journal:  Neurobiol Dis       Date:  2015-06-10       Impact factor: 5.996

3.  Increased plasma and brain immunoglobulin A in Alzheimer's disease is lost in apolipoprotein E ε4 carriers.

Authors:  Dovilė Pocevičiūtė; Cristina Nuñez-Diaz; Bodil Roth; Shorena Janelidze; Andreas Giannisis; Oskar Hansson; Malin Wennström
Journal:  Alzheimers Res Ther       Date:  2022-08-26       Impact factor: 8.823

4.  Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy.

Authors:  Andrew P Speidell; Tamar Demby; Yichien Lee; Olga Rodriguez; Christopher Albanese; Jeanne Mandelblatt; G William Rebeck
Journal:  Neurotox Res       Date:  2018-10-04       Impact factor: 3.911

5.  Decreased immunoglobulin G in brain regions of elder female APOE4-TR mice accompany with Aβ accumulation.

Authors:  Lihang Zhang; Juan Xu; Jinchao Gao; Peiqing Chen; Ming Yin; Wenjuan Zhao
Journal:  Immun Ageing       Date:  2019-01-25       Impact factor: 6.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.